Shelton Capital Management acquired a new stake in shares of Zoetis Inc. (NYSE:ZTS) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 3,718 shares of the company’s stock, valued at approximately $232,000.

Other hedge funds also recently bought and sold shares of the company. Northwestern Mutual Wealth Management Co. increased its position in Zoetis by 16.8% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,598 shares of the company’s stock valued at $100,000 after buying an additional 230 shares in the last quarter. Guardian Life Insurance Co. of America increased its position in Zoetis by 0.7% during the 1st quarter. Guardian Life Insurance Co. of America now owns 1,905 shares of the company’s stock valued at $102,000 after buying an additional 13 shares in the last quarter. Point72 Asia Hong Kong Ltd bought a new position in Zoetis during the 1st quarter valued at approximately $111,000. Harfst & Associates Inc. increased its position in Zoetis by 16.1% during the 2nd quarter. Harfst & Associates Inc. now owns 1,878 shares of the company’s stock valued at $117,000 after buying an additional 260 shares in the last quarter. Finally, Almanack Investment Partners LLC. bought a new position in Zoetis during the 2nd quarter valued at approximately $119,000. 93.19% of the stock is owned by institutional investors.

A number of research analysts recently weighed in on the company. BidaskClub raised Zoetis from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, September 12th. Zacks Investment Research raised Zoetis from a “hold” rating to a “buy” rating and set a $71.00 price objective for the company in a research report on Thursday, October 12th. Cowen and Company set a $70.00 price objective on Zoetis and gave the company a “buy” rating in a research report on Monday, July 17th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $75.00 price objective on shares of Zoetis in a research report on Tuesday, September 26th. Finally, Deutsche Bank AG reaffirmed a “buy” rating and set a $65.00 price objective (up previously from $62.00) on shares of Zoetis in a research report on Monday, July 17th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $65.76.

Shares of Zoetis Inc. (NYSE:ZTS) opened at 65.56 on Thursday. The firm has a 50 day moving average price of $64.23 and a 200-day moving average price of $61.18. Zoetis Inc. has a 12-month low of $46.86 and a 12-month high of $65.91. The company has a market cap of $32.07 billion, a price-to-earnings ratio of 37.06 and a beta of 1.02.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Tuesday, August 8th. The company reported $0.53 EPS for the quarter, meeting the consensus estimate of $0.53. Zoetis had a return on equity of 62.49% and a net margin of 17.50%. The firm had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the prior year, the business posted $0.49 EPS. The business’s revenue for the quarter was up 5.0% compared to the same quarter last year. On average, equities analysts expect that Zoetis Inc. will post $2.34 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 1st. Stockholders of record on Thursday, November 9th will be issued a dividend of $0.105 per share. The ex-dividend date is Wednesday, November 8th. This represents a $0.42 annualized dividend and a dividend yield of 0.64%. Zoetis’s dividend payout ratio is presently 23.73%.

TRADEMARK VIOLATION NOTICE: This story was originally reported by Daily Political and is the property of of Daily Political. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/10/19/shelton-capital-management-invests-232000-in-zoetis-inc-zts-stock.html.

Zoetis Company Profile

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.